Aging and interaction of natriuretic factors on renal and vascular sodium pump
Aging and interaction of natriuretic factors on renal and vascular sodium pump
批准号:
8552491
负责人:
Alexei Bagrov
金额:
$36.56万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
ATPase inhibitory proteinAgeAgingAmlodipineAntibodiesBlood VesselsCardiac GlycosidesCardiovascular systemCollagenDevicesElderlyErythrocytesExhibitsFemaleFluoroimmunoassayHourHydrochlorothiazideHypertensionIncidenceInfusion proceduresLisinoprilMeasuresNa(+)-K(+)-Exchanging ATPaseNatriuretic FactorsPatientsPhysiologic pulsePlasmaResistanceRoleSalineSodium Chloridearterial stiffnesskidney vascular structuremalemarinobufageninresponsesalt sensitivesex
中文摘要
我们对30例RH患者(男性15例,女性15例;55.6+/-1.3岁)进行了联合(赖诺普利/氨氯地平/氢氯噻嗪)治疗的研究。盐负荷(SL)通过静脉滴注1000mL生理盐水进行。1个小时。使用Fineter Pro设备注册心跳对心跳BP。用SPhygmoCor PX脉搏波传导速度(PWV)测定仪测量动脉硬度。用荧光免疫法和红细胞膜NKA活性测定血清MBG水平,在无和存在抗MBG单抗(MAb)体外治疗的情况下进行测量。
SL患者2小时内出现收缩压和舒张压升高(175+/-5vs.152+/-3和101+/-2vs.90+/-2,P均<0.01),血浆MBG升高(0.48+/-0.06vs.0.31+/-0.05nmoL/L),NKA抑制(1.49+/-0.09vs.2.11+/-0.07umol PI/ml/hr;P<;0.01)。抗MBG单抗体外恢复NKA(2.7+/-0.1umol PI/ml/hr;P<;0.01)。在男女患者中,SL的升压反应幅度与MBG水平和NKA活性无关,但在男性患者中,MBG引起的NKA抑制和SL刺激的MBG幅度与PVW呈正相关(分别为r=0.55,P=0.03和r=0.51,P=0.03),而在女性患者中无相关性(分别为r=0.15,P=0.57和r=0.22,P=0.41)。在男女患者中,MBG诱导的NKA抑制程度与年龄呈正相关(r=0.45;P=0.006)。
这些结果表明,在男性顽固性高血压患者中,MBG诱导的NKA抑制程度与BP本身的盐敏感性无关,而与患者的年龄和PVW有关,PVW是血管僵硬的主要特征,是心血管老化的主要特征。
英文摘要
We studied 30 patients (15 males and 15 females; 55.6 +/- 1.3 yrs) with RH on a combined (lisinopril/amlodipine/hydrochlorothiazide) therapy. Salt loading (SL) was performed via infusion of 1000 mL saline i.v. for 1 hour. Beat-to-beat BP was registered using Finometer Pro device. Arterial stiffness was measured by Sphygmocor Px device with a calculation of pulse wave velocity (PWV). Levels of MBG were estimated by fluoroimmunoassay and by activity of NKA in erythrocytes at baseline and following SL, measured in the absence and in the presence of a monoclonal anti-MBG antibody (mAb) ex-vivo treatment.
Within 2 hrs of SL patients exhibited elevation of systolic and diastolic BP (175 +/- 5 vs. 152 +/-3 and 101 +/- 2 vs. 90 +/- 2 mmHg, both P<0.01), increase in plasma MBG (0.48 +/- 0.06 vs. 0.31 +/- 0.05 nmol/L), and NKA inhibition (1.49 +/- 0.09 vs. 2.11 +/- 0.07 umol Pi/ml/hr; P<0.01). Anti-MBG mAb ex-vivo restored NKA (2.7 +/- 0.1 umol Pi/ml/hr; P<0.01). In patients of both sexes magnitude of pressor response to SL did not correlate with the levels of MBG and with NKA activity, but magnitude of MBG-induced NKA inhibition and of SL-stimulated MBG was positively associated with PVW in male (r=0.55, P=0.03, and r=0.51, P=0.03, respectively), but not in female subjects (r=0.15, P=0.57, and r=0.22, P=0.41, respectively). In patients of both sexes magnitude of MBG-induced NKA inhibition was positively associated with age (r=0.45; P=0.006).
These results indicate that in male patients with resistant hypertension magnitude of MBG-induced NKA inhibition associates not with the salt-sensitivity of BP per se, but with age of patients and with PVW, which characterizes vascular stiffness, a major feature of cardiovascular aging.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Aging and interaction of natriuretic factors on renal and vascular sodium pump
-
批准号:8736638
-
项目类别:
-
资助金额:$41.83万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Sodium Pump Inhibitors In Blood Pressure Regulation
-
批准号:8736576
-
项目类别:
-
资助金额:$43.8万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Marinobufagenin as a therapeutic target
-
批准号:9147364
-
项目类别:
-
资助金额:$54.3万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Development of a therapeutic anti-marinobufagenin antibody
-
批准号:8335946
-
项目类别:
-
资助金额:$37.73万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Aging and interaction of natriuretic factors on renal and vascular sodium pump
-
批准号:8335945
-
项目类别:
-
资助金额:$21.77万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Development of a therapeutic anti-marinobufagenin antibody
-
批准号:8148335
-
项目类别:
-
资助金额:$28.29万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Aging and interaction of natriuretic factors on renal and vascular sodium pump
-
批准号:9147363
-
项目类别:
-
资助金额:$63.45万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Development of a therapeutic anti-marinobufagenin antibody
-
批准号:7964071
-
项目类别:
-
资助金额:$44.05万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Sodium Pump Inhibitors In Blood Pressure Regulation
-
批准号:8335876
-
项目类别:
-
资助金额:$26.12万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Development of a therapeutic anti-marinobufagenin antibody
-
批准号:8552492
-
项目类别:
-
资助金额:$61.48万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Development of a therapeutic anti-marinobufagenin antibody
-
批准号:8931610
-
项目类别:
-
资助金额:$56.62万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Sodium Pump Inhibitors In Blood Pressure Regulation
-
批准号:7963990
-
项目类别:
-
资助金额:$35.01万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Aging and interaction of natriuretic factors on renal and vascular sodium pump
-
批准号:8931609
-
项目类别:
-
资助金额:$56.62万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Sodium Pump Inhibitors In Blood Pressure Regulation
-
批准号:8148271
-
项目类别:
-
资助金额:$19.59万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Development of a therapeutic anti-marinobufagenin antibody
-
批准号:7732338
-
项目类别:
-
资助金额:$46.67万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Aging and interaction of natriuretic factors on renal and vascular sodium pump
-
批准号:7732337
-
项目类别:
-
资助金额:$38.89万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Sodium pump inhibitors in blood pressure regulation and in profibrotic signaling in salt sensitive hypertension and aging
-
批准号:8931554
-
项目类别:
-
资助金额:$56.88万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Aging and interaction of natriuretic factors on renal and vascular sodium pump
-
批准号:7964070
-
项目类别:
-
资助金额:$32.75万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Aging and interaction of natriuretic factors on renal and vascular sodium pump
-
批准号:8148334
-
项目类别:
-
资助金额:$16.32万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Sodium Pump Inhibitors In Blood Pressure Regulation
-
批准号:8552423
-
项目类别:
-
资助金额:$58.16万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: